France has declared itself to be free of highly pathogenic avian influenza in the absence of new outbreaks for more than a month, though the country remains on high alert for the virus that has been spreading rapidly in Europe, the agriculture ministry said.
This cross-sectional study examines the use, spending, and prices of adalimumab biosimilars in the first year of market competition in the US.
Celltrion’s CT-P43/ustekinumab-stba has been approved under the name Steqeyma and is expected to launch in February 2025.
Swiss pharmaceutical group Novartis is winding up the German biotech company Morphosys, which it acquired at the beginning of the year, German news outlet WirtschaftsWoche…
AI tools excel at qualitative analysis, but stumble with quantitative work
We may have an answer to the “mystery illness” in the Democratic Republic of Congo. Here’s what the story reveals about America’s global health commitments.
Our findings indicate that mindfulness therapy significantly reduces the risk of depressive and anxiety symptoms in both high-risk pregnancy population and healthy populations. Therefore, when…
Scientists at the Department of Energy’s Oak Ridge National Laboratory have demonstrated an autonomous robotic field monitoring, sampling and data-gathering system that could accelerate understanding…
Far too often health and social care workers are blamed. The decision of the conservative government to prevent social care workers from bringing their families…
Should we regulate or even ban ultra-processed foods (UPFs)? This question is asked with increasing frequency, spurred by popular media interest in research that associates…
BENGALURU: Bengaluru-based Asia Healthcare Holdings (AHH) on Wednesday said that Singapore sovereign fund GIC will invest an additional $150 million in the heal
